Document is current

Chapter History

First Online: 5 January 2024

Conflicts of Interest

: G.C. reported honoraria for speaker’s engagements for: Roche, Seattle Genetics, Novartis, Lilly, Pfizer, Foundation Medicine, NanoString, Samsung, Celltrion, BMS and MSD; honoraria for providing consultancy for: Roche, Seattle Genetics and NanoString; honoraria for participating in Advisory Boards for: Roche, Lilly, Pfizer, Foundation Medicine, Samsung, Celltrion and Mylan; honoraria for writing engagements for: Novartis and BMS; honoraria for participation in Ellipsis Scientific Affairs Group; and institutional research funding for conducting phase I and II clinical trials for: Pfizer, Roche, Novartis, Sanofi, Celgene, Servier, Orion, AstraZeneca, Seattle Genetics, AbbVie, Tesaro, BMS, Merck Serono, Merck Sharp Dome, Janssen-Cilag, Philogen, Bayer, Medivation and Medimmune, all outside the submitted work. PZ, EN, CC, and CV do not report potential conflict of interest.